Aclasta is a solution used as an infusion to treat Osteoporosis. The infusion is given once a year.


Osteoporosis is a disease that involves the thinning and weakening of the bones and is common in women after the menopause, but can also occur in men. At menopause woman’s ovaries stop producing the female hormone oestrogen, which helps to keep bones healthy. Following menopause bones become weaker and break more easily.

Osteoporosis could also occur in men and women because of the long term use of steroids, which can affect the strength of bones. Many patients with osteoporosis have no symptoms but they are still at risk of breaking bones because osteoporosis has made their bones weaker. Decreased circulating levels of sex hormones, mainly oestrogens converted from androgens, also play a role in the more gradual bone loss observed in men.

In both women and men, Aclasta strengthens the bone and therefore makes it less likely to break.

Aclasta is also used in patients who have recently broken their hip in a minor trauma such as a fall and therefore are at risk of subsequent bone breaks.

What Aclasta is and what it is used for?

Aclasta contains the active substance zoledronic acid. It belongs to a group of medicines called bisphosphonates and is used to treat post-menopausal women and adult men with osteoporosis with a bone mineral density T-score of –2.5 or less and in established osteoporosis with any fracture due to minimal trauma.

How is it administered?

Aclasta is given intravenously . It is given as a once-yearly infusion. This can be administered at our infusion clinic. Our nurses are highly trained to monitor you during the infusion and watch for any symptoms.

Please book with our GPs to determine your suitability for this infusion. This is available at our Infusion clinic

Infusion Clinic GP's

Dr. S Athapattu

General Practitioner

Dr Ye

General Practitioner

Dr. R Khabaz

General Practitioner

Dr. M A Choong

General Practitioner